This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Valneva Austria Gmbh. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Martin Oleksiewicz: Innovator in Nucleic Acid Technologies
Introduction
Martin Oleksiewicz is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of isolated nucleic acid molecules. His work focuses on antigens related to nontypable species, which are crucial for understanding bacterial infections.
Latest Patents
Martin Oleksiewicz holds 1 patent that pertains to isolated nucleic acid molecules encoding an antigen from a nontypable species. This patent encompasses a vector containing such nucleic acid, as well as a host cell that includes this vector. The invention also details processes for producing antigens and antibodies associated with nontypable infections, along with methods for diagnosing and treating these infections.
Career Highlights
Martin is currently employed at Valneva Austria GmbH, where he continues to advance his research in the field of biotechnology. His innovative work has the potential to impact the development of pharmaceutical compositions aimed at combating bacterial infections.
Collaborations
Martin collaborates with esteemed colleagues such as Margarita Smidt and Andreas Meinke, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Martin Oleksiewicz is a prominent figure in the biotechnology sector, with a focus on nucleic acid technologies that address critical health challenges. His contributions are paving the way for advancements in the diagnosis and treatment of bacterial infections.